Skip to main content
SleepCited

Melatonin para Trastorno del Ritmo Circadiano

A

Basado en 104 estudios (7 meta-analyses, 6 RCTs) con 2,780 participantes en total. 58/104 estudios muestran efectos positivos.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dcircadian\u002Drhythm\u002Ddisorder'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Conclusión

Melatonin is well-supported by strong evidence as a supplement that may help reset disrupted circadian rhythms and internal body clock timing.

  • 104 studies including 7 meta-analyses and 6 RCTs — one of melatonin's best-studied uses
  • Recognized in clinical practice guidelines for circadian rhythm disorders
  • 56% of studies show clearly positive effects; others show mixed or context-dependent results
  • Research covers delayed sleep phase, irregular rhythms, and non-24-hour disorders

Key Study Findings

Observational Study n=55
Correlation between sleep problems and morning serum melatonin and ferritin levels in Japanese 5-year-old children …
Dose: None vs: None Outcome: correlation between sleep problems and morning serum melatonin … Efecto: None p<0.05

Población: Japanese 5-year-old children (45 ASD, 10 non-ASD)

Other
An HPLC-MS-Based Method for Determination of the D- and L- 5-Methyltetrahydrofolate Isomer Ratio in Dietary …
Dose: None vs: None Outcome: separation and quantification of D- and L-5-MTHF diastereomers … Efecto: None None

Población: None

Case Reports n=1 Open-label
A novel CSNK1Dvariant in pediatric advanced sleep-wake phase syndrome.
Dose: None vs: None Outcome: Sleep-wake phase improvement Efecto: None None

Población: 4-year-old girl with advanced sleep-wake phase disorder

In Vitro
Exogenous L-Cysteine and Its Transport Through CtaP Play a Role in Biofilm Formation, Swimming Motility, …
Dose: 1.57 and 3.67 mM vs: Basal defined media without L-cysteine Outcome: Biofilm formation and motility of L. monocytogenes Efecto: None None

Población: Listeria monocytogenes 10403S and ctaP mutant

Review
Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment.
Dose: None vs: None Outcome: ISWRD symptom management Efecto: None None

Población: Patients with irregular sleep-wake rhythm disorder

Key Statistics

176

Estudios

4513

Participantes

Mixed

A

Calificación

Referenced Papers

Handbook of clinical … 2025 10 citas
JAAPA : official … 2025 1 citas
Clinical psychopharmacology and … 2024 14 citas
Current neuropharmacology 2023 38 citas
Journal of clinical … 2023 6 citas
Neurologia 2022 78 citas
Archives of physiology … 2022 69 citas
Neurologia 2022 47 citas
Current neuropharmacology 2022 40 citas
Chronobiology international 2021 47 citas
Archives of medical … 2021 6 citas
Neurotherapeutics : the … 2020 80 citas
Journal of glaucoma 2020 32 citas
Current treatment options … 2020 29 citas
Current sleep medicine … 2019 28 citas
Journal of the … 2019 5 citas
Neurologic clinics 2019
Current neurology and … 2018 39 citas
Current biology : … 2017 455 citas
Neurological research 2017 331 citas
Continuum (Minneapolis, Minn.) 2017 132 citas
Current treatment options … 2017 56 citas
Annual review of … 2016 557 citas
Neuropsychiatric disease and … 2016 6 citas
Sleep medicine clinics 2015 75 citas
Sleep medicine clinics 2015 30 citas
Medwave 2015 6 citas
Journal of clinical … 2014 19 citas
Continuum (Minneapolis, Minn.) 2013 172 citas
Nihon rinsho. Japanese … 2013
Chronobiology international 2012 1248 citas
Postgraduate medicine 2011
Expert review of … 2010 58 citas
The International journal … 2010 55 citas
Travel medicine and … 2009 101 citas
Seminars in neurology 2009 17 citas
Tidsskrift for den … 2009 6 citas
Turk psikiyatri dergisi … 2009
Arzneimittel-Forschung 2008 89 citas
Behavioral sleep medicine 2007
The FEBS journal 2006 56 citas
Molecular and cellular … 2006 54 citas
Journal of biological … 2005 316 citas
Seminars in neurology 2004 16 citas
Journal of neuroendocrinology 2003 719 citas
Best practice & … 2003 339 citas
The Cochrane database … 2002 154 citas
Revista de neurologia 2002 35 citas
Neuro endocrinology letters 2002
The Cochrane database … 2001 154 citas
The American journal … 2000 472 citas
Medical science monitor … 2000 11 citas
Proceedings of the … 1999 96 citas
Reproduction, nutrition, development 1999 64 citas
Current treatment options … 1999 23 citas
European journal of … 1999
Nihon rinsho. Japanese … 1998
Chronobiology international 1997 135 citas
Medecine tropicale : … 1997
The Netherlands journal … 1996 13 citas
La Revue du … 1996
Journal of psychiatry … 1994 118 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
0.5-3 mg, 30-60 min before bed
jetlag:
0.5-5 mg

Límite superior: No established UL; 5 mg typically considered maximum

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Positive 55
None -- Neutral --
None -- Mixed --
None -- Positive 1
1.57 and 3.67 mM -- Mixed --
None -- Mixed --
None -- Positive --
20 mg or 50 mg tasimelteon daily 5 weeks Positive 322

Mejor momento para tomar: 30-60 minutes before bed

Safety & Side Effects

Efectos secundarios reportados

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams or nightmares

Interacciones conocidas

  • Blood thinners (warfarin) — may increase bleeding risk
  • Immunosuppressants — melatonin may stimulate immune function
  • Diabetes medications — may affect blood sugar levels
  • Sedatives and CNS depressants — additive drowsiness

Ingesta máxima tolerable: No established UL; 5 mg typically considered maximum

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Melatonin help with Trastorno del Ritmo Circadiano?
Based on 176 studies with 4,513 participants, there is strong evidence from multiple clinical trials that Melatonin may support Trastorno del Ritmo Circadiano management. Our evidence grade is A (Strong Evidence).
How much Melatonin should I take for Trastorno del Ritmo Circadiano?
Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Melatonin?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Melatonin and Trastorno del Ritmo Circadiano?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 176 peer-reviewed studies with 4,513 total participants. The overall direction of effect is mixed.

Related Evidence

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.